GlassScriptPhysician profile
Richard E Wood
NPI 1972591105
$1,873.84
in general payments reported to CMS, 2019-2025
21 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $130 · 2021: $283 · 2022: $250 · 2023: $150 · 2024: $354 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $544.60 | 2020-2025 | Tryptyr, Eysuvis, Simbrinza |
| Johnson & Johnson Vision Care, INC. | $200.17 | 2019-2024 | Acuvue |
| Kala Pharmaceuticals, INC. | $190.87 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $176.39 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $167.04 | 2022-2024 | Infuse, Vyzulta, Miebo |
| Shire North American Group INC | $98.40 | 2019 | |
| Biotissue Holdings INC. | $59.84 | 2021-2023 | |
| Oyster Point Pharma, INC. | $53.82 | 2022-2024 | Ryzumvi, Tyrvaya |
| Sun Pharmaceutical Industries INC. | $42.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.70 | 2020-2022 | |
| Coopervision INC. | $40.81 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $33.90 | 2019-2021 | |
| Harrow Eye, LLC | $33.86 | 2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $31.21 | 2025 | Xdemvy |
| Visioneering Technologies, INC. | $28.86 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $27.31 | 2024 | Oxervate |
| Abbvie INC. | $27.15 | 2022 | |
| Sight Sciences, INC. | $23.42 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Allergan, INC. | $17.56 | 2021 | |
| Thea Pharma INC. | $15.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.